We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,752 hedge funds and large institutions have $300B invested in Johnson & Johnson in 2023 Q2 according to their latest regulatory filings, with 189 funds opening new positions, 1,608 increasing their positions, 1,591 reducing their positions, and 134 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $4.22B | Put options by funds: $2.62B

41% more first-time investments, than exits

New positions opened: 189 | Existing positions closed: 134

7% more capital invested

Capital invested by funds: $280B → $300B (+$19.7B)

5% more funds holding in top 10

Funds holding in top 10: 436457 (+21)

1% more repeat investments, than reductions

Existing positions increased: 1,608 | Existing positions reduced: 1,591

0.78% more ownership

Funds ownership: 69.05%69.83% (+0.78%)

1% more funds holding

Funds holding: 3,7293,752 (+23)

Holders
3,752
Holders Change
+23
Holders Change %
+0.62%
% of All Funds
58.9%
Holding in Top 10
457
Holding in Top 10 Change
+21
Holding in Top 10 Change %
+4.82%
% of All Funds
7.17%
New
189
Increased
1,608
Reduced
1,591
Closed
134
Calls
$4.22B
Puts
$2.62B
Net Calls
+$1.6B
Net Calls Change
+$801M
Name Holding Trade Value Shares
Change
Change in
Stake
AP
1026
Americana Partners
Texas
$8.72M -$2.81M -17,391 -25%
MFS
1027
Mirabella Financial Services
United Kingdom
$8.69M +$7.7M +47,710 +993%
VCM
1028
Vision Capital Management
Oregon
$8.67M -$52.6K -326 -0.6%
SIS
1029
Sound Income Strategies
Florida
$8.63M +$627K +3,884 +8%
GIA
1030
Gladstone Institutional Advisory
Florida
$8.62M -$5.15M -31,896 -38%
HWAM
1031
Hennion & Walsh Asset Management
New Jersey
$8.62M +$421K +2,609 +5%
TCA
1032
Transcend Capital Advisors
New Jersey
$8.6M -$1.24M -7,701 -13%
NME
1033
Notis-McConarty Edward
$8.59M -$132K -820 -2%
SCP
1034
Stamos Capital Partners
California
$8.58M -$203K -1,260 -2%
IEFM
1035
IQ EQ Fund Management
Ireland
$8.57M -$96.5K -598 -1%
GIA
1036
GHP Investment Advisors
Colorado
$8.55M +$372K +2,303 +5%
PWP
1037
Perfromance Wealth Partners
Illinois
$8.54M -$317K -1,965 -4%
CCG
1038
Chatham Capital Group
Georgia
$8.53M +$191K +1,182 +2%
KIG
1039
Kessler Investment Group
Indiana
$8.52M +$56K +347 +0.7%
FFA
1040
First Foundation Advisors
California
$8.51M +$1.5M +9,297 +22%
AssetMark Inc
1041
AssetMark Inc
California
$8.51M +$216K +1,339 +3%
BIA
1042
Biondo Investment Advisors
Pennsylvania
$8.5M +$16.1K +100 +0.2%
EWM
1043
Executive Wealth Management
Michigan
$8.49M +$133K +823 +2%
DAS
1044
Dynamic Advisor Solutions
Arizona
$8.48M +$1.71M +10,573 +26%
OCM
1045
One Capital Management
California
$8.46M +$195K +1,209 +2%
IIM
1046
Ipswich Investment Management
Massachusetts
$8.45M -$95.7K -593 -1%
JIR
1047
James Investment Research
Ohio
$8.45M -$195K -1,209 -2%
WB
1048
Webster Bank
Connecticut
$8.45M -$161K -997 -2%
AAF
1049
Andra AP-fonden
Sweden
$8.44M -$1.28M -7,900 -13%
OHIS
1050
Oak Harvest Investment Services
Texas
$8.42M +$1.54M +9,555 +23%

JNJ Hedge Fund Activity: Q2 2023 in Review

3,752 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2023, worth a combined $300B — up 7% from $280B a quarter earlier.

Buyers outnumbered sellers: 189 funds opened new JNJ positions and 134 closed out — a net gain of 55 holders — while 1,608 added to existing stakes and 1,591 trimmed.

The largest buyer was Capital International Investors, adding an estimated $1.73B. The largest seller was Bank of America, cutting an estimated $822M.

  • 3,752 institutional investors held Johnson & Johnson (JNJ) as of Q2 2023, up from 3,729 in Q1 2023.
  • Funds reported $300B of Johnson & Johnson stock for Q2 2023, up 7% quarter-over-quarter.
  • 189 funds opened new Johnson & Johnson positions in Q2 2023 and 134 closed out, a net change of +55 holders.
  • The largest Johnson & Johnson buyer in Q2 2023 was Capital International Investors, an estimated $1.73B added.
  • The largest Johnson & Johnson seller in Q2 2023 was Bank of America, an estimated $822M sold.

Based on aggregated 13F filings for Q2 2023.